Clinical Report: The Role of Circular RNA circNUP214 in Myasthenia Gravis
Overview
This study investigates the role of circular RNA circNUP214 in myasthenia gravis (MG), highlighting its elevated expression in PBMCs and CD4+ T cells of MG patients. CircNUP214 promotes CD4+ T cell proliferation by sponging miR-31 and upregulating NFAT5.
Background
Myasthenia gravis (MG) is an autoimmune disorder characterized by muscle weakness due to autoantibodies targeting the neuromuscular junction. Dysregulated T-cell responses, particularly the over-activation of CD4+ T cells, play a crucial role in MG pathogenesis. Understanding the molecular mechanisms, such as the role of circular RNAs, is essential for developing targeted therapies.
Data Highlights
Parameter
MG Patients (n=31)
Healthy Controls (n=40)
circNUP214 Expression in PBMCs
Significantly Elevated
Normal
circNUP214 Expression in CD4+ T Cells
Elevated
Normal
Key Findings
CircNUP214 expression is significantly elevated in PBMCs of MG patients compared to healthy controls.
CircNUP214 is also elevated in CD4+ T cells from MG patients.
CircNUP214 promotes CD4+ T cell proliferation.
Knockdown of circNUP214 suppresses CD4+ T cell proliferation.
CircNUP214 directly binds miR-31 and upregulates NFAT5.
The circNUP214/miR-31/NFAT5 axis may contribute to CD4+ T cell dysfunction in MG.
Clinical Implications
The findings indicate the circNUP214/miR-31/NFAT5 axis's involvement in CD4+ T cell proliferation in MG.
Conclusion
CircNUP214 plays a significant role in the proliferation of CD4+ T cells in myasthenia gravis through its interaction with miR-31 and NFAT5.
